tyrosine has been researched along with Gaucher Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biton, I; Eilam, R; Farfel-Becker, T; Futerman, AH; Vitner, EB | 1 |
| Groth, CG; Ringdén, O | 1 |
| Perlmutter, DH; Teckman, J | 1 |
| Kane, PA; Karani, JB; Meili-Vergani, G; Williams, R | 1 |
| Ben-Yoseph, Y; Choy, FY; Humphries, ML | 1 |
| Beutler, E; Gelbart, T | 1 |
2 review(s) available for tyrosine and Gaucher Disease
| Article | Year |
|---|---|
Transplantation in relation to the treatment of inherited disease.
Topics: alpha 1-Antitrypsin Deficiency; Amyloidosis; Bone Marrow Transplantation; Fabry Disease; Gaucher Disease; Genetic Diseases, Inborn; Gout; Granulomatous Disease, Chronic; Hemoglobinopathies; Hemophilia A; Hepatolenticular Degeneration; Humans; Immunologic Deficiency Syndromes; Kidney Transplantation; Leukodystrophy, Metachromatic; Liver Transplantation; Lymphocytes; Metabolism, Inborn Errors; Mucopolysaccharidoses; Nephritis, Hereditary; Niemann-Pick Diseases; Osteopetrosis; Oxalates; Oxalic Acid; Transplantation; Tyrosine; Uremia | 1984 |
Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease.
Topics: alpha 1-Antitrypsin Deficiency; Child; Gaucher Disease; Hepatolenticular Degeneration; Humans; Liver Diseases; Metabolism, Inborn Errors; Tyrosine | 1995 |
4 other study(ies) available for tyrosine and Gaucher Disease
| Article | Year |
|---|---|
Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood-Brain Barrier; Calcium-Binding Proteins; Cell Death; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Gaucher Disease; Gene Expression Regulation, Developmental; Glucosylceramidase; Ibuprofen; Immunoglobulin G; Intercellular Adhesion Molecule-1; Intermediate Filament Proteins; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Microfilament Proteins; Microglia; Nerve Tissue Proteins; Nestin; Neurons; TATA Box; Tyrosine; Vascular Cell Adhesion Molecule-1 | 2012 |
Pseudotumours of hepatic imaging.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin Deficiency; Amino Acid Metabolism, Inborn Errors; Diagnosis, Differential; Gaucher Disease; Humans; Infant; Liver Diseases; Liver Failure; Liver Transplantation; Tomography, X-Ray Computed; Tyrosine | 1996 |
Gaucher type 2 disease: identification of a novel transversion mutation in a French-Irish patient.
Topics: Aspartic Acid; Female; France; Gaucher Disease; Glucosylceramidase; Humans; Infant; Ireland; Lysine; Point Mutation; Proline; Tyrosine | 1998 |
Gaucher disease associated with a unique KpnI restriction site: identification of the amino-acid substitution.
Topics: Base Sequence; Child; Deoxyribonucleases, Type II Site-Specific; DNA; Female; Gaucher Disease; Glucosidases; Glucosylceramidase; Humans; Molecular Sequence Data; Mutation; Phenylalanine; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pseudogenes; Restriction Mapping; Tyrosine | 1990 |